Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies

V Walker Harris, TT Brown - Journal of Infectious Diseases, 2012 - academic.oup.com
Osteoporosis is common in human immunodeficiency virus (HIV)–infected persons. The
etiology of osteoporosis in HIV-infected patients is likely multifactorial, involving traditional …

Secondary osteoporosis and metabolic bone diseases

MM Sobh, M Abdalbary, S Elnagar, E Nagy… - Journal of Clinical …, 2022 - mdpi.com
Fragility fracture is a worldwide problem and a main cause of disability and impaired quality
of life. It is primarily caused by osteoporosis, characterized by impaired bone quantity and or …

Metabolic bone disease in HIV infection

M Borderi, D Gibellini, F Vescini, E De Crignis… - Aids, 2009 - journals.lww.com
HIV mainly replicates in CD4þ T lymphocytes and monocyte/macrophages causing severe
immunological impairment. In addition to the immune system, HIV infection affects tissues …

gp120-derived amyloidogenic peptides form amyloid fibrils that increase HIV-1 infectivity

S Tan, W Li, C Yang, Q Zhan, K Lu, J Liu… - Cellular & Molecular …, 2024 - nature.com
Apart from mediating viral entry, the function of the free HIV-1 envelope protein (gp120) has
yet to be elucidated. Our group previously showed that EP2 derived from one β-strand in …

Consequences of HIV infection in the bone marrow niche

CL Herd, J Mellet, T Mashingaidze, C Durandt… - Frontiers in …, 2023 - frontiersin.org
Dysregulation of the bone marrow niche resulting from the direct and indirect effects of HIV
infection contributes to haematological abnormalities observed in HIV patients. The bone …

The HIV proteins T at and N ef promote human bone marrow mesenchymal stem cell senescence and alter osteoblastic differentiation

C Beaupere, M Garcia, J Larghero, B Fève… - Aging cell, 2015 - Wiley Online Library
To maintain bone mass turnover and bone mineral density (BMD), bone marrow (BM)
mesenchymal stem cells (MSC s) are constantly recruited and subsequently differentiated …

Influence of HIV infection and antiretroviral therapy on bone homeostasis

MV Delpino, J Quarleri - Frontiers in endocrinology, 2020 - frontiersin.org
The human immunodeficiency virus type 1 (HIV)/AIDS pandemic represents the most
significant global health challenge in modern history. This infection leads toward an …

HIV‐1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFα activation

D Gibellini, E De Crignis, C Ponti… - Journal of medical …, 2008 - Wiley Online Library
Several HIV‐1 infected patients show bone loss and osteopenia/osteoporosis during the
course of disease. The mechanisms underlying this degenerative process are largely …

First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir

MGA van Vonderen, P Lips, MA van Agtmael… - Aids, 2009 - journals.lww.com
Objective: We studied changes in bone mineral density (BMD) and bone turnover after
initiation of combination antiretroviral therapy (cART) and the contribution of …

Role of inflammation in HIV-1 disease progression and prognosis

H Ipp, AE Zemlin, RT Erasmus… - Critical reviews in clinical …, 2014 - Taylor & Francis
Inflammation and immune activation have been thrust to center stage in the understanding
of HIV-1 disease pathogenesis and progression. Early work demonstrated that heightened …